president trump glp 1 GLP-1 price reduction: announces agreement on drugs Could the price of GLP-1
Description
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
Glycemic monitoring with CGMs, glucose-lowering agents (GLP-1 receptor agonists), innovative insulin delivery systems, and mental health check-ins are just a few updates to the ADA 2025 Standards of Care.
As a result, they are effective treatment options for people with T2D, achieving glycated haemoglobin reductions, weight loss and potential cardiovascular benefit, as monotherapy or as add-on to other glucose-lowering therapies
rapid absorption, easy to take (just 2ml) and can be conveniently mixed into beveragesno large pills to swallow Ideal for Diverse Lifestyles: GLP-1 Supplement Liquid Drops Perfectly suited for Keto, Kosher, Vegan, and Gluten-Free diets
Listen now | While were away this holiday season, we will be publishing a few of our favourite essays from this year, read out by AI.
2024 in Review: The Rise of GLP-1 Medications for Weight Loss
